Ligand receives US$ 6.5 mn from Roche for progression of RG7348 into phase-I trial in treatment of HCV infection

Ligand receives US$ 6.5 mn from Roche for progression of RG7348 into phase-I trial in treatment of HCV infection
Ligand Pharmaceuticals Incorporated announced that it earned a US$ 6.5 million payment from Roche as a result of Roche progressing RG7348 into a phase-I clinical trial for the treatment of hepatitis C viral (HCV) infection.
Read more on [...]

Study finds variation in H1N1 infection risks and antibody levels: JAMA

Study finds variation in H1N1 infection risks and antibody levels: JAMA
An analysis of blood samples taken before, during and after an epidemic wave of influenza A(H1N1) in Singapore in 2009 finds variation in infection risks and antibody levels, with younger age groups and military personnel having higher infection rates than other groups, according to a [...]